GLP-1 Receptor Agonist Market Key Takeaways Eli Lilly and Company, Sanofi, Novo-Nordisk A/S, AstraZeneca, Pfizer, Inc., Amgen, Inc., Innovent Biologics, Inc., PegBio Co., Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH Increasing prevalence of chronic diseases such as diabetes and obesity Increasing R&D activities for developing novel therapeutics Formulation advancements of oral GLP-1 receptor agonists Adverse effects associated with few GLP-1 agonist drugs Product recalls by market players With the increasing prevalence of diabetes and obesity, GLP-1 receptor agonists have become popular due to their effectiveness in glycemic control and weight reduction, offering a dual benefit in managing type 2 diabetes mellitus (T2DM)
Ngoi ra, nhiu sn phm cn cha thm ng, carb v mt s thnh phn khc
SA00001-1) antibodies were obtained from Proteintech (Wuhan, China)
How It Works in Your Body The injection spot can change how well the medication does its job
Only a small percentage of people require hemorrhoid surgery, and we will almost always prescribe it after other, less invasive procedures have failed
Cazanave, S
